NFKB1 and urinary bladder carcinoma: The PI3K/AKT pathway is also overactivated in bladder cancer, promoting cell proliferation, survival, and metastasis, and the NF-kB pathway inhibitor (NFKBIZ) can inhibit tumor cell proliferation through the PTEN/PI3K/Akt signaling pathway [33].